Skip to content
Clinical Trials – home

Centro Medico Teknon-Grupo Quironsalud

Research site

Spain Calle Vilana 12, 08022 Barcelona, Spain

  • 11 trials recruiting
  • Colitis ulcerative · Crohn's disease · Chronic rhinosinusitis with nasal polyps
  • Adults and children

About Specializations

Centro Medico Teknon-Grupo Quironsalud in Barcelona, Spain specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Chronic rhinosinusitis with nasal polyps, Dry age-related macular degeneration, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

The Sleep Unit at Centro Medico Teknon-Grupo Quironsalud is investigating Crohn's disease, focusing on the safety and tolerability of a novel subcutaneous therapy.

  • Safety profiling of RO7790121 in moderate to severe Crohn’s disease
  • Evaluation of patient‑reported outcomes
  • Integration of endoscopic biomarkers

Three active trials involve ten investigators, advancing therapeutic options for digestive disorders.

Female Urogenital Diseases and Pregnancy Complications

Researchers are studying sleep disturbances associated with menopause and testing the efficacy of the new compound elinzanetant using polysomnography.

  • Efficacy of elinzanetant on sleep architecture
  • Safety monitoring in post‑menopausal women
  • Quality‑of‑life assessments

The goal is to expand safe treatment choices for women experiencing menopausal sleep problems.

Nutritional and Metabolic Diseases

The site’s program includes research on obesity, evaluating the cardiovascular safety of the investigational agent BI 456906 in overweight participants.

  • Cardiovascular event monitoring
  • Metabolic parameter analysis
  • Long‑term weight change evaluation

Findings will inform whether this therapy offers a safer approach to weight management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Calle Vilana 1208022 BarcelonaSpain
Recruiting now
11 trials
Conditions studied
16

More sites in BarcelonaSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

32 clinical trials

A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:XMAB942
  • Sponsor:Xencor Inc.

Crohn's disease

Recruiting

Testing SAR442970 compared to placebo in adults with moderate to severe Crohn's disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:SAR442970
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Study on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Eli Lilly & Co.

A Phase 3 Randomized, Double-blind,Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-2)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Obesity

Recruiting

RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Study of Maridebart Cafraglutide for Adults with Obstructive Sleep Apnea and Overweight or Obesity Who Use Positive Airway Pressure Therapy

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Study on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:F. Hoffmann-La Roche AG

Study on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Janssen Cilag International

A study to evaluate the safety and effectiveness of ADX-038 in adults with geographic atrophy caused by age-related macular degeneration.

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ADX-038
  • Sponsor:Adarx Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.